Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Skin Neoplasms
×
MAPRE1 protein, human
×
Clear all
Filters
3
NCT04349436
2026-02-27
ARTACUS
Replimune Inc.
Phase 1/2
Recruiting
90 enrolled